Septerna, Inc. Common Stock (SEPN) support and resistance · rev $46.0M
Septerna, Inc. Common Stock (SEPN) is a biotechnology company listed on NASDAQ.
This page maps Septerna, Inc. Common Stock (SEPN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SEPN revenue for 2025-12-31 was $46.0M. Net income was -$48.9M. Revenue was up 4174.5% from 2024-12-31 to 2025-12-31. SEPN currently screens at market cap $1.61B.
SEPN currently screens at market cap $1.61B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SEPN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SEPN quote page for the session range and the stock page for the full model.
Not investment advice.